MaxCyte Inc. announced that Chief Financial Officer Douglas Swirsky will transition from his role in the first half of 2026. The company has begun searching for his successor. Swirsky will remain CFO until a replacement is appointed and will then serve in an advisory capacity to support the transition. The company expects no impact on its operations or strategic priorities during this period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MaxCyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9574469-en) on November 12, 2025, and is solely responsible for the information contained therein.
Comments